English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45422/58598 (78%)
造訪人次 : 2541314      線上人數 : 186
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/6481


    題名: Sulfanilamide 和 Thiazole 的Imide衍生物合成及生物活性之研究
    Study on the Synthesis and Bioactivity of Sulfanilamide and Thiazole analogues
    作者: 戴秀玲
    Hsiu-Ling Dai
    貢獻者: 藥學研究所
    關鍵詞: 磺胺藥


    醯亞胺
    斑蝥素
    Sulfanilamide
    Thiazole
    Imide
    cantharidin
    日期: 2003
    上傳時間: 2009-09-11 16:56:57 (UTC+8)
    摘要: 中文摘要
    Sulfanilamide 和 Thiazole 的Imide
    衍生物合成及生物活性之研究
    磺胺藥在臨床上為葉酸拮抗劑,用於治療細菌感染,另一方面sulfanilamide為重要的活性官能基,以其為lead molecule發展出多種廣泛不同活性的藥物,包括:抗菌劑,碳酸酐脢抑制劑、利尿劑、降血糖劑、抗HIV病毒、metalloprotease 抑制劑等;根據最近的文獻報導,一群新的sulfanilamide衍生物在體內及體外試驗皆顯示具抗腫瘤活性,它們具有共同的芳香環/異環sulfanilamide 結構,其抗癌基轉包括: 抑制碳酸酐脢,破壞細胞週期G1期,阻止微小管聚合,抑制轉錄活化因子NF-Y功能,及抑制血管增生等;其SAR探討結果顯示,sulfanilamide為活性必要基團,因此我們嘗試以sulfanilamide為起始原料,以各種酸酐類化合物合成一系列之磺胺衍生物,先前本實驗室已將磺胺類衍化合物導入cantharidin 合成一系列醯亞胺化合物,並發現部分化合物有抗肝癌活性,因此本實驗室進一步利用各式酸酐類化合物取代cantharidin之結構,合成得到一系列之磺胺衍生物(compounds 1-34),藉由以下方法:將sulfaniamide 和酸酐化合物置於高壓封管,加熱到200℃反應兩個小時,待冷卻後,進行脫水反應,利用TLC Plate純化,另一thiazole系列(compounds 35-57),也藉由同樣的反應條件合成。合成的化合物,已由核磁共振儀、紅外光光譜儀、質譜儀確定結構。此外也針對磺胺衍生物在抗肝癌細胞藥理活性測試, 結果顯示sulfanilamide 衍生物大部分不具細胞毒性,而另一系列thiazole衍生物 細胞毒性則待測中。
    Study on the Synthesis and Bioactivity of
    Sulfanilamide and Thiazole analogues
    Abstract
    The sulfanilamides were the first effective antibacterial drug which is folic acid antagonist. The sulfanilamide lead molecule constituted the basis for the development of all these types of pharmacological agents which such a varied spectrum of biological actions, as exemplified below for antibacterial agent, carbonic anhydrase inhibitor, diuretic agent, hypoglycemic agent, HIV protease inhibitor, metalloprotease inhibitor. A host of structurally novel sulfonamide derivatives have recently been reported to show substantial antitumor activity in vitro and in vivo. Although they have a common chemical motif of aromatic/ heterocyclic sulfonamide, there are a variety of mechanisms of their antitumor action, such as carbonic anhydrase inhibition, cell cycle arrest in the G1 phase, disruption of microtuble assembly, functional suppression of the transcription activitor NF-Y, and angiogenesis ( matreix metalloproteinase) inhibition among others. Previously, we usedsulfanilamide analogues to attach cantharidin to synthesis a series of imide compounds and founded a part compounds had antihepatocellular carcinoma activity. In order to further structural study, we used various anhydrides replace the structure of cantharidin to synthesis a series of sulfanilamides analogues
    ( compounds 1- 34) by the following method: sulfanilamide or other
    analogues were dealed with various anhydrides by heated to 200℃ in a sealed tube for 2 hours. After cooling, the residuals were removed from the tube, and were further evaporated and purified by TLC plate. Another series of thiazole analogues (compounds 35-57) were synthesized by the same method. All of these sulfanilamide and thiazole imide analogues were measured by H-NMR, IR, mass spectrometry. Besides, the series synthetic compounds of the sulfa and thiazole were tested for their capability to suppress growth of human hepatocellular carcinoma cell line. The data indicated that almost compounds of sulfanilamide are non- cytotoxicity. Another series of thiazole analogues would be tested .
    資料類型: thesis
    顯示於類別:[藥學系] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    摘要.doc29KbMicrosoft Word158檢視/開啟
    摘要.pdf1034KbAdobe PDF131檢視/開啟
    摘要.ppt123KbMicrosoft Powerpoint154檢視/開啟
    摘要.ps520KbPostscript44檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋